Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PEP005 topical: Preliminary Phase IIa data

Preliminary data from an open-label Phase IIa trial in 86 evaluable

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE